Results of innovative triple negative breast cancer project paves the way for new six-year study to improve response to immunotherapy
Research newsPromising results of his team’s research into the extracellular matrix of triple negative breast cancer has led Dr Oliver Pearce to being awarded a CRUK Career Establishment Award of over £800,000 to continue and develop his work for a further six years. Dr Pearce was the first recipient of a seed grant following our call …
Read more